HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

K Fizazi Selected Research

Nonseminomatous germ cell tumor

2/2013Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
5/2007Refining the optimal chemotherapy regimen for good-risk metastatic nonseminomatous germ-cell tumors: a randomized trial of the Genito-Urinary Group of the French Federation of Cancer Centers (GETUG T93BP).
8/2004Oxaliplatin in non-seminomatous germ-cell tumors.
9/2003Acute respiratory distress syndrome after chemotherapy for lung metastases from non-seminomatous germ-cell tumors.
1/2002A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


K Fizazi Research Topics

Disease

43Prostatic Neoplasms (Prostate Cancer)
12/2023 - 07/2001
17Neoplasm Metastasis (Metastasis)
12/2023 - 11/2001
17Neoplasms (Cancer)
01/2023 - 02/2000
11Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
09/2014 - 02/2000
5Pain (Aches)
01/2021 - 03/2010
5Nonseminomatous germ cell tumor
02/2013 - 01/2002
4Carcinoma (Carcinomatosis)
03/2012 - 04/2001
3Disease Progression
08/2015 - 09/2001
3Seminoma
03/2012 - 03/2001
3Renal Cell Carcinoma (Grawitz Tumor)
10/2010 - 06/2000
3Malignant Mesothelioma
01/2003 - 06/2000
3Colorectal Neoplasms (Colorectal Cancer)
08/2001 - 02/2000
2Fatigue
02/2014 - 04/2013
2Kidney Neoplasms (Kidney Cancer)
10/2011 - 05/2010
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
08/2010 - 09/2003
2Circulating Neoplastic Cells
04/2009 - 03/2007
2Mesothelioma
01/2003 - 08/2000
2Breast Neoplasms (Breast Cancer)
11/2001 - 09/2001
1Virus Diseases (Viral Diseases)
01/2023
1Immune System Diseases (Immune Disorders)
01/2023
1Infections
01/2023
1Coinfection
01/2023
1Cytokine Release Syndrome
01/2023
1Bone Fractures (Bone Fracture)
01/2021
1Spinal Cord Compression
02/2015
1Spontaneous Fractures (Pathological Fracture)
02/2015
1Gestational Trophoblastic Disease (Trophoblastic Neoplasms, Gestational)
08/2014
1Diarrhea
02/2014
1Edema (Dropsy)
02/2014
1Headache (Headaches)
06/2013
1Bone Diseases (Bone Disease)
05/2012
1Osteonecrosis (Kienbock's Disease)
05/2012
1Testicular Neoplasms (Testicular Cancer)
03/2012

Drug/Important Bio-Agent (IBA)

15Docetaxel (Taxotere)FDA Link
12/2023 - 10/2007
12Cisplatin (Platino)FDA LinkGeneric
09/2014 - 08/2000
8Oxaliplatin (Eloxatin)FDA LinkGeneric
08/2008 - 06/2000
7Abiraterone AcetateIBA
01/2021 - 04/2013
7AndrogensIBA
01/2018 - 03/2010
5Hormones (Hormone)IBA
01/2021 - 12/2006
5Prednisone (Sone)FDA LinkGeneric
01/2020 - 01/2012
5Diphosphonates (Bisphosphonates)IBA
02/2015 - 03/2010
4enzalutamideIBA
10/2021 - 07/2013
4Zoledronic Acid (Zometa)FDA Link
01/2018 - 09/2010
4Etoposide (VP 16)FDA LinkGeneric
08/2014 - 04/2001
3Biomarkers (Surrogate Marker)IBA
12/2023 - 04/2009
3cabazitaxelFDA Link
10/2021 - 01/2017
3Androgen Receptors (Androgen Receptor)IBA
01/2021 - 07/2013
3GemcitabineFDA Link
05/2014 - 06/2006
3raltitrexed (D 1694)IBA
01/2003 - 06/2000
3Fluorouracil (Carac)FDA LinkGeneric
08/2001 - 06/2000
2abirateroneIBA
10/2021 - 01/2017
2collagen type I trimeric cross-linked peptideIBA
01/2016 - 09/2010
2DenosumabFDA Link
01/2016 - 02/2015
2IfosfamideFDA LinkGeneric
05/2014 - 11/2002
2Angiogenesis InhibitorsIBA
05/2012 - 10/2011
2PlatinumIBA
01/2012 - 03/2005
2EstramustineFDA Link
01/2010 - 09/2001
2Phosphotransferases (Kinase)IBA
11/2007 - 10/2007
2Tyrosine (L-Tyrosine)FDA Link
11/2007 - 10/2007
2Bleomycin (Blenoxane)FDA LinkGeneric
05/2007 - 01/2002
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2002 - 01/2002
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2002 - 01/2002
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2002 - 01/2002
2Taxoids (Taxanes)IBA
11/2001 - 09/2001
2AnthracyclinesIBA
11/2001 - 09/2001
1Interleukin-6 (Interleukin 6)IBA
01/2023
1darolutamideIBA
01/2021
1Circulating Tumor DNAIBA
01/2021
1Prednisolone (Predate)FDA LinkGeneric
01/2018
1antiarrhythmic peptide (AAP)IBA
01/2018
1Analgesics (Analgesic Drugs)IBA
11/2017
1tasquinimodIBA
11/2017
1Alkaline PhosphataseIBA
03/2016
1AlbuminsIBA
03/2016
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2016
1VimentinIBA
02/2016
1Dactinomycin (Actinomycin)FDA LinkGeneric
08/2014
1ZD4054IBA
06/2013
1Tumor Biomarkers (Tumor Markers)IBA
02/2013
1Platelet-Derived Growth FactorIBA
05/2012
1LigandsIBA
05/2012
1Thalidomide (Thalomid)FDA Link
05/2012
1VaccinesIBA
05/2012
1src-Family KinasesIBA
05/2012
1RadiopharmaceuticalsIBA
05/2012
1Endothelin-1 (Endothelin 1)IBA
05/2012
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
05/2012
1Monoclonal AntibodiesIBA
01/2012
1Mitoxantrone (Novantrone)FDA LinkGeneric
01/2012
1siltuximabIBA
01/2012

Therapy/Procedure

33Drug Therapy (Chemotherapy)
01/2021 - 02/2000
30Castration
12/2023 - 10/2007
27Therapeutics
01/2023 - 02/2000
5Radiotherapy
10/2017 - 03/2001
2Salvage Therapy
09/2014 - 11/2001
2Prostatectomy (Retropubic Prostatectomy)
03/2007 - 12/2006
2Lymph Node Excision (Lymph Node Dissection)
09/2001 - 10/2000
1Palliative Care (Palliative Therapy)
01/2019
1Hematopoietic Stem Cell Transplantation
09/2014
1Adjuvant Radiotherapy
03/2012